Showing results (171-180 of 186) with videos related to
Sort By:
Pageof 19
Journal of Crohn'S & Colitis|July 7, 2012
The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern EuropePeter L Lakatos, Barbara D Lovasz, Gyula David, et al.World Journal of Gastroenterology|November 5, 2010
NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patientsNora Meggyesi, Lajos S Kiss, Magdalena Koszarska, et al.Journal of Crohn'S & Colitis|December 3, 2010
Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel diseasePeter Laszlo Lakatos, Zsofia Czegledi, Gyula David, et al.Orvosi Hetilap|February 6, 2010
[Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease]László Lakatos, Zsófia Czeglédi, Gyula Dávid, et al.Inflammatory Bowel Diseases|February 13, 2013
Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohortPeter L Lakatos, Zsuzsanna Vegh, Barbara D Lovasz, et al.Proceedings of the National Academy of Sciences of the United States of America|September 27, 2001
Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental strokeJ Huang, D B Agus, C J Winfree, et al.Radiation Research|April 14, 2023
RENEB Inter-Laboratory Comparison 2021: The Gene Expression AssayM Abend, S A Amundson, C Badie, et al.Scientific Reports|May 8, 2021
Inter-laboratory comparison of gene expression biodosimetry for protracted radiation exposures as part of the RENEB and EURADOS WG10 2019 exerciseM Abend, S A Amundson, C Badie, et al.Radiology|September 1, 1996
Patellar tendinosis (jumper's knee): findings at histopathologic examination, US, and MR imaging. Victorian Institute of Sport Tendon Study GroupK M Khan, F Bonar, P M Desmond, et al.Alimentary Pharmacology & Therapeutics|September 3, 2011
Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's diseaseL S Kiss, T Szamosi, T Molnar, et al.Pageof 19